Extrawell Pharmaceutical Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG3285Q1134
HKD
0.09
0.01 (5.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
600.77
769.36
653.29
518.15
630.14
554.29
Shareholder's Funds
600.77
769.36
653.29
518.15
630.14
554.29
Minority Interest
-0.51
-0.15
-0.73
-1.21
-2.65
-5.08
Long-Term Borrowings
630.86
612.29
597.63
584.11
573.00
561.99
Secured Loans
630.86
612.29
597.63
584.11
573.00
561.99
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-0.07
-0.07
-0.07
-0.07
-0.07
-0.07
Other Long Term Liabilities
1.91
3.29
0.04
2.12
3.89
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
631.39
614.27
595.47
584.46
575.20
561.99
Current Liabilities
Trade Payables
4.66
6.63
6.46
6.69
6.24
8.12
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
51.37
57.01
64.06
57.89
58.33
79.74
Total Liabilities
1,287.19
1,444.87
1,317.10
1,164.24
1,265.71
1,196.09
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
191.53
196.22
207.29
199.46
186.78
184.56
Less: Accumulated Depreciation
65.49
59.67
58.90
55.90
46.70
43.82
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
126.04
136.54
148.39
143.56
140.07
140.74
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
981.83
1,127.79
972.45
807.72
914.66
835.59
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
1,109.75
1,266.21
1,122.72
953.16
1,056.62
987.44
Current Assets Loans & Advances
Current Investments
0.66
1.75
1.91
1.79
1.65
1.77
Inventories
7.88
3.92
12.63
8.21
8.48
9.31
Sundry Debtors
4.21
5.80
7.81
9.13
10.48
20.05
Cash and Bank
114.47
122.20
133.62
148.40
147.93
169.90
Other Current Assets
175.57
175.37
192.25
209.54
207.42
207.21
Short Term Loans and Advances
48.35
41.70
36.28
42.01
38.87
6.19
Total Current Assets
177.44
178.66
194.38
211.08
209.09
208.64
Net Current Assets (Including Current Investments)
126.07
121.65
130.32
153.19
150.76
128.90
Total Current Assets Excluding Current Investments
177.44
178.66
194.38
211.08
209.09
208.64
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,287.19
1,444.87
1,317.10
1,164.24
1,265.71
1,196.09
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
630.86
612.29
597.63
584.11
573.00
561.99
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2024 is 3.03% vs 2.61% in Mar 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2024 is -41.95% vs 8,125.00% in Mar 2023

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2024 is -7.69% vs -7.99% in Mar 2023

stock-summary

Investments

YoY Growth in year ended Mar 2024 is -12.94% vs 15.97% in Mar 2023

stock-summary

Current Assets

YoY Growth in year ended Mar 2024 is -0.68% vs -8.09% in Mar 2023

Compare Balance Sheet Results of Extrawell Pharmaceutical Holdings Ltd.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
600.77
342.66
258.11
75.33%
Shareholder's Funds
600.77
342.66
258.11
75.33%
Minority Interest
-0.51
31.52
-32.03
-101.62%
Long-Term Borrowings
630.86
43.81
587.05
1,339.99%
Secured Loans
630.86
43.81
587.05
1,339.99%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.07
0.91
-0.98
-107.69%
Other Long Term Liabilities
1.91
3.73
-1.82
-48.79%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
631.39
5.34
626.05
11,723.78%
Current Liabilities
Trade Payables
4.66
15.20
-10.54
-69.34%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
51.37
121.57
-70.20
-57.74%
Total Liabilities
1,287.19
501.09
786.10
156.88%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
191.53
107.53
84.00
78.12%
Less: Accumulated Depreciation
65.49
1.39
64.10
4,611.51%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
126.04
106.14
19.90
18.75%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
981.83
2.08
979.75
47,103.37%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0
0.00
0.00%
Total Non-Current Assets
1,109.75
112.07
997.68
890.23%
Current Assets Loans & Advances
Current Investments
0.66
0.15
0.51
340.00%
Inventories
7.88
10.50
-2.62
-24.95%
Sundry Debtors
4.21
10.17
-5.96
-58.60%
Cash and Bank
114.47
362.29
-247.82
-68.40%
Other Current Assets
175.57
387.16
-211.59
-54.65%
Short Term Loans and Advances
48.35
4.05
44.30
1,093.83%
Total Current Assets
177.44
389.02
-211.58
-54.39%
Net Current Assets (Including Current Investments)
126.07
267.45
-141.38
-52.86%
Total Current Assets Excluding Current Investments
177.44
389.02
-211.58
-54.39%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,287.19
501.09
786.10
156.88%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
630.86
43.81
587.05
1,339.99%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 629.48 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is 3.03% vs 2.61% in Mar 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.91 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is -41.95% vs 8,125.00% in Mar 2023

Annual - Fixed Assets
Fixed Assets 126.04 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is -7.69% vs -7.99% in Mar 2023

Annual - Investments
Investments 981.83 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is -12.94% vs 15.97% in Mar 2023

Annual - Current Assets
Current Assets 177.44 Million
in Mar 2024

Figures in Million
stock-summary

YoY Growth in year ended Mar 2024 is -0.68% vs -8.09% in Mar 2023